Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 10:11:626.
doi: 10.3389/fnins.2017.00626. eCollection 2017.

Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins

Affiliations
Review

Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins

Jesús Avila et al. Front Neurosci. .

Abstract

Molecular changes associated with neuronal aging lead to a decrease in cognitive capacity. Here we discuss these alterations at the level of brain regions, brain cells, and brain membrane and cytoskeletal proteins with an special focus in NMDA molecular changes through aging and its effect in cognitive decline and Alzheimer disease. Here, we propose that some neurodegenerative disorders, like Alzheimer's disease (AD), are characterized by an increase and acceleration of some of these changes.

Keywords: cognition; dendritic spines; neurotransmitter agents; tau proteins; therapies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Partial view of actin cytoskeleton in dendritic spines. Scaffold proteins involved in anchoring of NMDA receptors to actin cytoskeleton. NMDAR, N-methyl-D-aspartate receptor; PSD-95, post-synaptic density protein 95; GKAP, guanylate kinase-associated protein; Shank, SH3 and ankyrin repeat-containing protein; SPAR, spine-associated RapGAP; KALI-7, kalirin-7.
Figure 2
Figure 2
Proposed movement, by lateral diffusion, of NMDA receptors from dendritic spines to extrasynaptic sites. Unbalance between synaptic and extrasynaptic NMDAR may contribute to cognitive decline in neuronal aging and neurodegenerative diseases as Alzheimer disease.
Figure 3
Figure 3
Indirect interaction between Aβ and tau through the NMDA receptor and fyn kinase. Two of the main molecular markers involved in Alzheimer disease, Aβ and tau, may require for their toxic effects of NMDAR-PSD-95 playing a role the kinase Fyn to alter post-synaptic density.
Figure 4
Figure 4
Different levels to study the changes that occur in the brain during aging. An alteration at any of these levels can cause cognitive impairment.

References

    1. Akashi K., Kakizaki T., Kamiya H., Fukaya M., Yamasaki M., Abe M., et al. (2009). NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, post-synaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J. Neurosci. 29, 10869–10882. 10.1523/JNEUROSCI.5531-08.2009 - DOI - PMC - PubMed
    1. Amar F., Sherman M. A., Rush T., Larson M., Boyle G., Chang L., et al. . (2017). The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation. Sci. Signal. 10:eaal2021. 10.1126/scisignal.aal2021 - DOI - PMC - PubMed
    1. Anacker C., Hen R. (2017). Adult hippocampal neurogenesis and cognitive flexibility-linking memory and mood. Nat. Rev. Neurosci. 18, 335–346. 10.1038/nrn.2017.45 - DOI - PMC - PubMed
    1. Ardestani P. M., Evans A. K., Yi B., Nguyen T., Coutellier L., Shamloo M. (2017). Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology 116, 371–386. 10.1016/j.neuropharm.2017.01.010 - DOI - PMC - PubMed
    1. Avila J., de Barreda E. G., Pallas-Bazarra N., Hernandez F. (2013). Tau and neuron aging. Aging Dis. 4, 23–28. - PMC - PubMed

LinkOut - more resources